Stoke Therapeutics, Inc. (STOK)
30.45
-2.55
(-7.73%)
USD |
NASDAQ |
Dec 09, 16:00
35.07
+4.62
(+15.17%)
After-Hours: 17:12
Stoke Therapeutics EPS Diluted (Quarterly): -0.6543 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 3.171 |
| Janux Therapeutics, Inc. | -0.392 |
| Insmed, Inc. | -1.747 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.35M |
| Revenue (Quarterly) | 10.63M |
| Total Expenses (Quarterly) | 48.98M |
| Enterprise Value | 1.641B |
| Gross Profit Margin (Quarterly) | 90.70% |
| Profit Margin (Quarterly) | -360.7% |
| Earnings Yield | 2.17% |
| Operating Earnings Yield | 1.53% |
| Normalized Earnings Yield | 2.167 |